ONCY
Oncolytics Biotech Inc
0.5958$
-0.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -18.6% | – | – | – | – | – | – | -21.0% | +58.3% | -49.7% | +14.7% | +0.1% | -0.8% | -2.0% | -2.6% | -1.7% | -0.3% | +7.4% | +39.3% | +15.0% | -41.8% | +0.5% | – | – | -5.3% | +338.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +59.3% | -33.5% | +28.7% | -40.8% | +43.6% | +18.4% | -30.3% | -5.7% | +30.0% | +21.7% | +11.7% | -51.3% | +69.3% | -10.0% | -1.2% | +54.2% | +5.4% | -32.1% | +16.1% | +2.4% | +12.2% | +0.8% | -13.6% | +14.8% | +31.6% | -26.9% | +4.6% | +57.0% | -19.8% | +23.3% | -20.6% | +49.1% | -64.2% | +15.2% | -26.7% | +163.0% | -45.1% | +53.7% | -6.4% | – | |
| – | +8.3% | +0.0% | +13.2% | -9.3% | +64.8% | -18.3% | -7.0% | -10.4% | -36.2% | +91.4% | +0.5% | +1.9% | +125.3% | -93.0% | – | – | – | – | – | +0.0% | +31.3% | -31.1% | +5.5% | -16.7% | +60.5% | -12.9% | +8.3% | +51.4% | -22.0% | -30.0% | +14.1% | -8.1% | -33.3% | +11.0% | -7.8% | +118.6% | +54.0% | -31.4% | +8.2% | – | |
| – | +55.4% | -31.7% | +22.3% | -30.4% | +52.7% | +1.3% | -21.6% | -7.8% | +43.7% | -0.8% | +7.6% | -33.7% | +101.1% | -20.5% | +0.4% | +13.8% | +27.8% | -26.9% | +14.0% | -8.5% | +21.1% | -15.4% | -4.2% | +0.2% | +40.4% | -20.8% | +6.3% | +54.3% | -19.9% | -1.4% | -9.2% | +25.0% | -52.2% | +6.2% | -16.9% | +138.5% | -2.9% | -3.8% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | -58.0% | +174.6% | – | – | – | – | – | – | – | – | +0.0% | +162.3% | +198.6% | +114.2% | -5.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,808.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -99.4% | +41.3% | -288.8% | – | -99.9% | +456,365.0% | -100.0% | +7.6% | -100.0% | – | – | +16,186.1% | -147.5% | – | -66.2% | +190.3% | -57.5% | -2.2% | -98.6% | +491.2% | +2,116.1% | -97.3% | -92.0% | +2,729.0% | -120.0% | – | -85.1% | +514.3% | +85.4% | +19.2% | -87.4% | -5.1% | – | – | -391.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,808.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.